Leech Biotechnology, Defining New Standards of Potency.
English
| Place of Origin: | China |
|---|---|
| Brand Name: | yichilam |
| Certification: | ISO9001；ISO45001；ISO12001；FDA；GMP |
| Model Number: | yzl-d-011 |
| Packaging Details: | Standard Packages |
| Delivery Time: | 10-20 Days |
| Payment Terms: | T/T, L/C, D/P, Western Union |
| Supply Ability: | Medical leech factory: annual output > 100 million medical leeches |
| Productname: | Leech Powder | Latin Name: | Hirudo Nipponia |
|---|---|---|---|
| Purity: | ≥98% | Shelf Life: | 36 Months |
| Store: | Freeze(-20℃±5℃） | Content: | 700ATU/g |
| Highlight: | Innovative Leech Powder,Leech Powder For Therapeutic,Hirudo Nipponica For Therapeutic |
||
Presenting our Peak Potency Leech Powder, the definitive achievement in bioactive concentration. Representing the frontier of our proprietary science, this ingredient is standardized to a guaranteed minimum of 700 Anti-Thrombin Units (AT-U) per gram of natural hirudin. It is engineered for the most demanding applications in advanced therapeutic research, elite nutraceutical formulation, and next-generation biomedical innovation where maximum specific activity is non-negotiable.
| Parameter | Specification & Assurance |
|---|---|
| Source & Authenticity | Hirudo nipponica (Proprietary High-Yield Strain, DNA Barcoded) |
| Guaranteed Specific Activity | ≥ 700 AT-U/g (Validated via Dual-Method Assay: SEC-HPLC & Chromogenic Substrate) |
| Manufacturing Standard | Produced in an ISO 9001-aligned, cGMP facility dedicated to high-potency actives. |
| Physical Characteristics | Ultrafine, crystalline-grade powder (Particle Size D90 ≤ 30 µm). Low electrostatic charge for superior handling. |
| Bioactive Profile | Ultra-concentrated Hirudin, with preserved native protein folding and co-active enzyme profiles. |
| Purity & Safety | Exceeds pharmaceutical-grade impurity limits (ICH Q3D). Full spectrum contaminant screening includes residual solvents, endotoxins (< 10 EU/mg), and specific pathogens. |
| Stability Data | Real-time and accelerated stability studies confirm exceptional activity retention, supported by a validated stability-indicating assay (SIA). |
1. Unmatched Specific Activity – The 700 AT-U/g Benchmark
This product sets a new global industry standard for natural hirudin concentration. It enables the development of ultra-low dose, high-impact formulations for maximum bioavailability and unprecedented efficacy claims, creating a clear category leader.
2. Proprietary "HirudinMAX" Biosynthesis Platform
This potency is the result of our integrated "HirudinMAX" platform:
Strain Optimization: Advanced biomolecular techniques are applied to our closed-cycle breeding program to maximize hirudin expression.
Bio-Convergent Processing: A synergistic, multi-parameter controlled process (temperature, pH, enzymatic inhibition) that captures and stabilizes the full bioactive potential at the moment of harvest, minimizing any activity loss.
3. Engineered for Sophisticated Delivery & Research
The exceptional purity, solubility, and specific activity make it the ideal candidate for:
Injectable-grade intermediates (for research purposes).
High-load sublingual or fast-dissolve tablets.
Precision-dosed clinical trial materials and advanced pharmacokinetic studies.
Cutting-edge biomaterial research (e.g., bioactive coatings for medical devices).
4. Comprehensive Regulatory & Scientific Partnership
We provide an unparalleled Master File Package designed to support regulatory filings (e.g., as a New Dietary Ingredient (NDI) dossier in the US, or novel food application in the EU). This includes full CMC (Chemistry, Manufacturing, and Controls) data, toxicological risk assessment, and proposed specifications.
Advanced Clinical Research & Therapeutics: The premier candidate material for Phase I/II human clinical trials investigating high-dose hirudin protocols for specific health outcomes.
Ultra-Premium Nutraceuticals: For formulating the ultimate "connoisseur-grade" dietary supplement, targeting niche, high-knowledge consumer segments.
Biopharmaceutical R&D: Critical raw material for research in novel anticoagulant therapies, targeted drug delivery systems, and regenerative medicine.
Reference Standard: As a high-potency benchmark for analytical laboratories and quality control departments.
Primary Packaging: 100g, 250g, or 500g in sterilizable, nitrogen-backfilled glass vials sealed with fluoropolymer-coated stoppers and aluminum caps, or in customized bulk packaging.
Storage Instructions: Must be stored frozen (-20°C ± 5°C) to guarantee long-term stability. Short-term transport on dry ice is recommended.
Shelf Life: 48 months from the date of manufacture when stored continuously at -20°C. 12 months when stored refrigerated (2-8°C).
This product is the culmination of over two decades of pioneering work by Jingzhou Min Kang Biotechnology Co., Ltd., the global authority in the industrial cultivation and biotechnological application of Hirudo nipponica.
Unmatched Vertical Integration: We control the world's most advanced, fully integrated pipeline—from our exclusive, state-certified breeding base (Hubei Provincial Leech Breeding Farm) to GMP extraction and finished product manufacturing. This ensures absolute control over genetics, purity, and traceability.
Science-Driven Innovation: Our expertise is validated through deep academic collaboration (e.g., with Hubei University of Chinese Medicine) and protected by a portfolio of core patents. We move beyond traditional use into the realm of standardized, high-potency bioactives.
Commitment to Excellence: Recognized as a National High-Tech Enterprise and featured on CCTV's flagship programs, our commitment to quality and innovation is nationally endorsed.
Our Promise: We bridge profound traditional knowledge with cutting-edge science to deliver not just an ingredient, but a trusted, scientifically-validated foundation for your most advanced product concepts.
Partner with us to define the future of bioactive wellness.
Critical Notice: This item is an upstream industrial input supplied exclusively to B2B partners (certified manufacturers) and research organizations. End consumers are not the intended audience. Product attributes are characterized against our supplier's control standards. Purchasers are responsible for ensuring suitability for their intended industrial or research application. Quality documentation (CoA) is provided to qualified buyers.